Live feed
Filing
SC 13D/A
SC 13D/A0000950103-16-014470·CASI Pharmaceuticals, Inc (DE)
Schedule 13D ownership disclosure
CASI PHARMACEUTICALS INC
Security class unavailable · CUSIP: 14757U109
Event date: 2016-06-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,198,518
- Percent of class
- 20.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950103-16-014470
- Form type
- SC 13D/A
- Filer
- CASI Pharmaceuticals, Inc (DE)
- CIK
- CIK 895051
- Filed
- Jun 30, 2016
- Reporting period
- Jun 24, 2016
- Description
- Schedule 13D beneficial ownership